› Forums › General Melanoma Community › KRAS mutation treatment?
- This topic is empty.
- Post
-
- October 2, 2012 at 5:07 am
Some melanomas have KRAS, some have both KRAS andBRAF.
http://www.sciencedaily.com/releases/2012/01/120111090607.htm
Some melanomas have KRAS, some have both KRAS andBRAF.
http://www.sciencedaily.com/releases/2012/01/120111090607.htm
Ganetespib Showed Activity in KRAS-Mutant NSCLC as Monotherapy and in Combinations
ScienceDaily (Jan. 10, 2012) — The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active when combined with traditional lung cancer treatments and other investigational targeted therapies, according to preclinical study data.
Share This:David A. Proia, Ph.D., and Jaime Acquaviva, Ph.D., scientists at Synta Pharmaceuticals Corp., presented the data at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012.
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.